Picture your Future. Save for it by earning 1.5% on a 1-year Term Deposit Account! Learn more.

Morningstar Views: What If Inflation Isn’t Dead?

By John Rekenthaler, a columnist for Morningstar.com and a member of Morningstar’s investment research department. 

A Long Silence

The last time that inflation was this dormant, Neville Chamberlain began the year as the United Kingdom’s prime minister and three cans of Campbell’s Tomato Soup cost $0.25. The year was 1940, and not only had inflation not reached 4% during any calendar year of the previous two decades, but eight of those 20 occasions also suffered deflation.

Although recent years haven’t featured deflation, save for 2009, today’s low-inflation streak is even longer. Not since 1991 has calendar-year inflation surpassed 4%. Consequently, the market’s inflation expectations, as implied by Treasury yields, are an all-time low. In the early ’40s, payouts on 10-year Treasuries bottomed at just below 2%. That note’s yield is now 0.56%.

That investors have become nonchalant about inflation may be witnessed by the distinctly muted reaction to the federal government’s recent stimulus efforts. In 2009, an $800 billion recovery bill prompted widespread unease about growth in the federal debt. In contrast, this year’s $2 trillion CARES Act, accompanied by the suggestion of an additional stimulus bill, has elicited few complaints.

Another perspective: The Congressional Budget Office forecasts that the United States will run a $3.7 trillion budget deficit in fiscal 2020, which represents 18% of expected gross domestic product. That will almost double 2009’s shortfall, as measured by that same ratio of deficit/GDP. That 18% percentage has been exceeded in modern U.S. history only by the World War II years of 1943, 1944, and 1945, and barely at that.

Rising national debt no longer seems to trouble bond-fund managers. Those who fussed about such things have been chased out of the business, replaced by pragmatists who cannot explain exactly why what they learned in their macroeconomics classes no longer applies but who know what happens to investment managers who habitually underperform their peers. Let economists sort out the theories; fund managers have a job to do and shareholders to satisfy.

This approach may continue to succeed. If investment professionals struggle to understand why inflation remains so quiet, far be it for me to provide the answer. Nor am I terribly concerned that the marketplace has become so complacent. While the popularity of bonds triggers my contrarian impulses, I have learned the hard way that sometimes the crowd is correct. For example, 10 years ago critics disparaged the development of a “bond bubble” based largely on the premise that all those individual investors couldn’t be right. So far, they have been.

Wartime Economies

Perhaps 2020 will later be recognized as the turning point, the year when inflation was finally rekindled. So far, that has been anything but the case. The bond markets have been delighted by the worldwide slowdown created by the appearance of the coronavirus. That reaction certainly makes sense for the near term. With spending depressed and global economies shrinking, inflation is currently but a concept. It will be a while before prices can increase.

However, warns Bill Bernstein (a financial theorist and neurologist), when the coronavirus is finally subdued, danger may await. The analogy is of a war economy. While the battle against COVID-19 is metaphorical, as it is waged with social distancing and ventilators rather than tanks, bullets, and drone strikes, it resembles a wartime activity in that resources have been diverted. Consumer spending is depressed, and, for those who have retained their jobs, assets are accumulating. Eventually, per the wartime thesis, this pent-up demand will explode, thereby sparking inflation.

That certainly has occurred in the past. Inflation in the United States exploded after World War I, then again after WWII, and then again after Vietnam. (The latter, admittedly, was greatly exacerbated by the Oil Crisis, which was a separate and distinct problem.) The lone exception among the past century’s four major conflicts was the Korean War, although inflation briefly spiked a couple of years after its conclusion, before once again subsiding.

The analogy, to be sure, is imperfect. While wartime economies typically bring increased employment, the COVID-19 pandemic has sidelined workers. Global economies are slack, as opposed to stretched by the addition of wartime projects. Nor, for the most part, could the world’s COVID-19 response be classified as a figurative version of total war. Only a small portion of the global economy is being employed against the pandemic.

Nonetheless, the resemblance is sufficiently strong to merit concern. Also worth considering is that eventually global developed governments may decide to inflate their way out of their national debts. They did not make that choice after the 2009 financial crisis, but debt levels were lower then. For example, in 2010, the United States had a debt/GDP ratio of 54%, as opposed to 101% currently.

Practical Implications

As a reminder–this being familiar territory–the best assets for an inflationary environment are cash, inflation-adjusted bonds, and commodities. Equities aren’t as attractive but neither are they terrible, because over time corporate earnings tend to rise with inflation. Then come junk bonds and finally, at the bottom of the list, the high-quality bonds that have performed so well in 2020.

Three modifications can improve a portfolio’s inflation resistance: 1) moving high-quality bonds for cash and/or Treasury Inflation-Protected Securities; 2) shifting some assets from equities to commodities, and 3) swapping high-growth stocks for value stocks. (Inflation hurts growth stocks more than their cheaper rivals because the cash flows that accrue to growth companies tend to occur further in the future. That is, growth stocks have longer durations.)

I do not necessarily advocate these transactions. Doing so would overstate my confidence that inflation will indeed resurface. (To paraphrase Warren Buffett when a highly credible investment source–such as Bill Bernstein–attempts the perilous task of predicting macroeconomic events, it is usually the reputation for peril that remains intact.) However, they are worth considering, particularly if the trades align with other reasons for adjusting one’s portfolio.

John Rekenthaler has been researching the fund industry since 1988. He is now a columnist for Morningstar.com and a member of Morningstar’s investment research department. John is quick to point out that while Morningstar typically agrees with the views of the Rekenthaler Report, his views are his own.

 


Morningstar Disclaimers:

Since its original publication, this piece may have been edited to reflect the regulatory requirements of regions outside of the country it was originally published in.

The opinions, information, data, and analyses presented herein do not constitute investment advice; are provided as of the date written; and are subject to change without notice. Every effort has been made to ensure the accuracy of the information provided, but Morningstar makes no warranty, express or implied regarding such information. The information presented herein will be deemed to be superseded by any subsequent versions of this document. Except as otherwise required by law, Morningstar, Inc or its subsidiaries shall not be responsible for any trading decisions, damages or losses resulting from, or related to, the information, data, analyses or opinions or their use. Past performance is not a guide to future returns. The value of investments may go down as well as up and an investor may not get back the amount invested. Reference to any specific security is not a recommendation to buy or sell that security. It is important to note that investments in securities involve risk, including as a result of market and general economic conditions, and will not always be profitable. Indexes are unmanaged and not available for direct investment.

This commentary may contain certain forward-looking statements. We use words such as “expects”, “anticipates”, “believes”, “estimates”, “forecasts”, and similar expressions to identify forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results to differ materially and/or substantially from any future results, performance or achievements expressed or implied by those projected in the forward-looking statements for any reason.

The Report and its contents are not directed to, or intended for distribution to or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction where such distribution, publication, availability or use would be contrary to law or regulation or which would subject Morningstar or its subsidiaries or affiliates to any registration or licensing requirements in such jurisdiction.


MeDirect Disclaimers:

This information has been accurately reproduced, as received from Morningstar, Inc. No information has been omitted which would render the reproduced information inaccurate or misleading. This information is being distributed by MeDirect Bank (Malta) plc to its customers. The information contained in this document is for general information purposes only and is not intended to provide legal or other professional advice nor does it commit MeDirect Bank (Malta) plc to any obligation whatsoever. The information available in this document is not intended to be a suggestion, recommendation or
solicitation to buy, hold or sell, any securities and is not guaranteed as to accuracy or completeness.

The financial instruments discussed in the document may not be suitable for all investors and investors must make their own informed decisions and seek their own advice regarding the appropriateness of investing in financial instruments or implementing strategies discussed herein.

If you invest in this product you may lose some or all of the money you invest. The value of your investment may go down as well as up. A commission or sales fee may be charged at the time of the initial purchase for an investment and may be deducted from the invested amount therefore lowering the size of your investment. Any income you get from this investment may go down as well as up. This product may be affected by changes in currency exchange rate movements thereby affecting your
investment return therefrom. Any decision to invest should always be based upon the details
contained in the Prospectus and Key Investor Information Document (KIID), which may be obtained from MeDirect Bank (Malta)
plc.

Share on facebook
Share on linkedin

Experience better banking

The sooner you start managing your money, your way, using the best-in-class tools, the sooner you’ll see results. Sign up and open your account for free, within minutes.

Latest news articles

All News

BlackRock Commentary: Why we still prefer stocks over bonds

Equities have fallen hard this year on the prospect of rapid rate increases to rein in inflation, the tragic Ukraine war and a slowdown in China. BlackRock think equities remain more attractive than bonds, even as the historic sell-off in bonds has cut the gap between the two.

All News

Notes from the Trading Desk – Franklin Templeton

Given recent declines, there is much discussion around what is priced into market. With global markets declining for six consecutive weeks, there is an increasing debate over how much bad news is priced in, and whether markets are now oversold.

Login

We strive to ensure a streamlined account opening process, via a structured and clear set of requirements and personalised assistance during the initial communication stages. If you are interested in opening a corporate account with MeDirect, please complete an Account Opening Information Questionnaire and send it to corporate@medirect.com.mt.

For a comprehensive list of documentation required to open a corporate account please contact us by email at corporate@medirect.com.mt or by phone on (+356) 2557 4444.